ACTRN12621000048886终止未知
The feasibility and efficacy of self-collected nasopharyngeal specimens for COVID-19 detection in an Australian oncology population
Icon Cancer Centre0 个研究点目标入组 22 人开始时间: 2021年1月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 终止
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patient is clinically and pathologically diagnosed with cancerous malignancy
- •Patient is receiving active treatment for their cancer at one of the participating Icon Cancer Centre’s
- •Patient is 18 years or older
- •Patient is capable of performing all protocol-related procedures (including the ability to return the sample to Sonic HealthCare laboratory)
- •Patient or legal representative capable of giving written and signed informed consent prior to performing any protocol-related procedures
排除标准
- •Patients who decline to perform self-collected test
- •Patients who have undergone nasal surgery in the past 2 weeks
- •Patients with acute facial trauma
研究者
相似试验
尚未招募
不适用
Implementation of a guideline-based cardiovascular risk assessment and decision aid tool for General Practice (CHAT-GP)Cardiovascular diseaseCardiovascular - Other cardiovascular diseasesPublic Health - Health service researchACTRN12621000583842niversity of Sydney24
已完成
不适用
A study on the usefulness of self-harvesting of HPV test and Chlamydia testCervical cancer Chlamydia infectionJPRN-UMIN000034949Marunouchi no Mori Ladies Clinic50
进行中（未招募）
1 期
Clinical trial to evaluate the efficacy and safety of bone marrow stem cell treatment for Asherman´s Syndrome patientsAsherman's syndrome also known as intrauterine synechiaeMedDRA version: 21.1Level: PTClassification code 10053868Term: Asherman's syndromeSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2016-003975-23-ESAsherman Therapy S.L.U.22
招募中
1 期
Fibroblast in Cutaneous LeishmaniasisIRCT20150715023218N1Iran University of Medical Sciences5
已完成
不适用
Development and validation of a self-administered Diabetes Drug Discontinuation (DDD) questionnaireCTRI/2021/01/030473ucknow Diabetes Study Society673